IL6 and type 2 diabetes mellitus: MyD88 signaling induces adipose <i>IL-6</i> and <i>CCL2</i>, liver inflammation and gluconeogenesis, and blood DPP4 activity by reducing IL-10 and Foxp3 of adipose tissue in T2DM.